Tecfidera to be funded in New Zealand

New Zealand multiple sclerosis (MS) patients will soon have affordable access to an additional option for the treatment of relapsing multiple sclerosis (MS) with news that PHARMAC will fund TECFIDERA® (dimethyl fumarate). To read more, click on the link below:

TECFIDERA®Available in NZ